Literature DB >> 8849230

Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan.

H Ohno1, H Koga, S Kohno, T Tashiro, K Hara.   

Abstract

We analyzed the relationship between rifampin MICs and rpoB mutations of 40 clinical isolates of Mycobacterium tuberculosis. A point mutation in either codon 516, 526, or 531 was found in 13 strains requiring MICs of > or = 64 micrograms/ml, while 21 strains requiring MICs of < or = 1 microgram/ml showed no alteration in these codons. However, 3 of these 21 strains contained a point mutation in either codon 515 or 533. Of the other six strains requiring MICs between 2 and 32 micrograms/ml, three contained a point mutation in codon 516 or 526, while no alteration was detected in the other three. Our results indicate that the sequencing analysis of a 69-bp fragment in the rpoB gene is useful in predicting rifampin-resistant phenotypes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8849230      PMCID: PMC163262     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Emergence of drug-resistant Mycobacterium tuberculosis in HIV-infected patients.

Authors:  L Monno; G Angarano; S Carbonara; S Coppola; D Costa; M Quarto; G Pastore
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

2.  Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  T Yamada; A Nagata; Y Ono; Y Suzuki; T Yamanouchi
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

3.  Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis.

Authors:  T Bodmer; G Zürcher; P Imboden; A Telenti
Journal:  J Antimicrob Chemother       Date:  1995-02       Impact factor: 5.790

4.  Nested polymerase chain reaction for detection of Mycobacterium tuberculosis in clinical samples.

Authors:  Y Miyazaki; H Koga; S Kohno; M Kaku
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

5.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

6.  Characterization of a Mycobacterium tuberculosis insertion sequence, IS6110, and its application in diagnosis.

Authors:  D Thierry; A Brisson-Noël; V Vincent-Lévy-Frébault; S Nguyen; J L Guesdon; B Gicquel
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Polymerase chain reaction for detection of Mycobacterium tuberculosis.

Authors:  U Sjöbring; M Mecklenburg; A B Andersen; H Miörner
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

8.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

9.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.

Authors:  B R Edlin; J I Tokars; M H Grieco; J T Crawford; J Williams; E M Sordillo; K R Ong; J O Kilburn; S W Dooley; K G Castro
Journal:  N Engl J Med       Date:  1992-06-04       Impact factor: 91.245

10.  The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.

Authors:  Y Zhang; B Heym; B Allen; D Young; S Cole
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

View more
  65 in total

1.  Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis.

Authors:  M Heep; U Rieger; D Beck; N Lehn
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins.

Authors:  M Heep; S Odenbreit; D Beck; J Decker; E Prohaska; U Rieger; N Lehn
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  rpoB mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy.

Authors:  G Pozzi; M Meloni; E Iona; G Orrù; O F Thoresen; M L Ricci; M R Oggioni; L Fattorini; G Orefici
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

4.  rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.

Authors:  Lishi Qian; Chiyoji Abe; Tao-Ping Lin; Ming-Chih Yu; Sang-Nae Cho; Sumin Wang; James T Douglas
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

5.  Rifampin and rifabutin resistance mechanism in Helicobacter pylori.

Authors:  M Heep; D Beck; E Bayerdörffer; N Lehn
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.

Authors:  Yaoju Tan; Zuqiong Hu; Yanlin Zhao; Xingshan Cai; Chunming Luo; Cairong Zou; Xin Liu
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

7.  Low-stringency single-specific-primer PCR as a tool for detection of mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis.

Authors:  Wania S Carvalho; Silvana Spindola de Miranda; Kátia M Costa; José G V C Araújo; Claudio J Augusto; João B Pesquero; Jorge L Pesquero; Maria A Gomes
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  rpoB mutations in Streptococcus mitis clinical isolates resistant to rifampin.

Authors:  Wafa Achour; Olfa Guenni; Marguerite Fines; Roland Leclercq; Assia Ben Hassen
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

9.  Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations.

Authors:  S Sreevatsan; K E Stockbauer; X Pan; B N Kreiswirth; S L Moghazeh; W R Jacobs; A Telenti; J M Musser
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

10.  Interaction of CarD with RNA polymerase mediates Mycobacterium tuberculosis viability, rifampin resistance, and pathogenesis.

Authors:  Leslie A Weiss; Phillip G Harrison; Bryce E Nickels; Michael S Glickman; Elizabeth A Campbell; Seth A Darst; Christina L Stallings
Journal:  J Bacteriol       Date:  2012-08-17       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.